Y. Mi

发表

Metabolic Disorders Combined with Noninvasive Tests to Screen Advanced Fibrosis in Nonalcoholic Fatty Liver Disease

J. Shang, Jian-Gao Fan, R. Zheng, 2021, Journal of clinical and translational hepatology.

PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism

Q. Su, Q. Pan, Yu-Qin Wang, 2017, Journal of diabetes research.

Functional magnetic resonance imaging-based assessment of terlipressin vs. octreotide on renal function in cirrhotic patients with acute variceal bleeding (CHESS1903): study protocol of a multicenter randomized controlled trial.

X. Qi, J. Lei, Jun Ye, 2019, Annals of translational medicine.

Genome-wide analysis of DNA methylation in human peripheral leukocytes identifies potential biomarkers of nonalcoholic fatty liver disease.

Q. Pan, Jian-Gao Fan, R. Zheng, 2018, International journal of molecular medicine.

Thyroid-stimulating hormone is associated with nonalcoholic steatohepatitis in patients with chronic hepatitis B

Peng Zhang, Ping Li, Y. Mi, 2019, Medicine.

APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver Diseases

Q. Pan, Jian-Gao Fan, R. Zheng, 2016, Digestive Diseases and Sciences.

Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis

Q. Pan, Jian-Gao Fan, Xi-qi Hu, 2019, Alimentary pharmacology & therapeutics.

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease

Q. Pan, R. Zheng, Lei-ming Xu, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder

Q. Ning, Xiaojing Wang, Xiaoping Luo, 2020, Theranostics.

The pathologic relevance of metabolic criteria in patients with biopsy-proven non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China.

J. Shang, Jian-Gao Fan, R. Zheng, 2021, Hepatobiliary & pancreatic diseases international : HBPD INT.

Letter to the editor: Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study

M. Zeng, Y. Mi, Liang Xu, 2022, Hepatology.

Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial

J. Bajaj, Xuan Zhu, J. Shang, 2019, Journal of digestive diseases.

Relationship between thyroid function and nonalcoholic fatty liver disease in patients with chronic hepatitis B

Peng Zhang, Ping Li, Y. Mi, 2019, World Chinese Journal of Digestology.

An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir

Yan Peng, Zhan-qing Zhang, Jiabin Li, 2022, Journal of clinical and translational hepatology.

Linked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.

Yi-Ming Chen, Q. Pan, Yu-Qin Wang, 2015, World journal of gastroenterology.

Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients.

P. Ma, Xiaoya Zheng, Y. Mi, 2020, Virus research.

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.

M. Kumar, V. Wong, V. de Lédinghen, 2017, Journal of hepatology.

Epidemiological and clinical characteristics of bacteremic brucellosis

Y. Mi, Yamin Liu, C. Qie, 2020, The Journal of international medical research.

Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients.

H. Cao, Q. Pan, Jian-Gao Fan, 2014, World journal of gastroenterology.

HIV-1 genetic diversity and high prevalence of pretreatment drug resistance in Tianjin, China.

P. Ma, X. Gong, Liying Gao, 2020, AIDS research and human retroviruses.

Controlled Attenuation Parameter for Noninvasive Assessment of Hepatic Steatosis Using Fibroscan®: Validation in Chronic Hepatitis B

W. Lu, Jian-Gao Fan, Ping Li, 2014, Digestive Diseases and Sciences.

Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement

M. Kumar, V. Wong, V. de Lédinghen, 2018, Alimentary pharmacology & therapeutics.

[Value of a two-step approach with cytokeratin-18 and controlled attenuation parameter in noninvasive differential diagnosis of nonalcoholic steatohepatitis].

Q. Pan, R. Zheng, Y. Mi, 2016, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study

V. Wong, J. Dufour, J. Schattenberg, 2023, Chinese medical journal.

Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD

W. Lu, Zhilong Jiang, Ping Li, 2016, The Korean journal of internal medicine.

[A serum lipidomic study of patients with non-alcoholic fatty liver disease].

Q. Pan, Y. Mi, F. Shen, 2017, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B.

W. Lu, Jian-Gao Fan, Ping Li, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.